The Rationale for and Clinical Pharmacology of Prasugrel 5 mg
Crossref DOI link: https://doi.org/10.1007/s40256-016-0202-3
Published Online: 2016-11-17
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jakubowski, Joseph A.
Erlinge, David
Alexopoulos, Dimitrios
Small, David S.
Winters, Kenneth J.
Gurbel, Paul A.
Angiolillo, Dominick J.
Funding for this research was provided by:
Eli Lilly and Company
License valid from 2016-11-17